Archives for February 21, 2011

← 2011

Kancera buys CRO iNovacia

By Gareth Macdonald

Sweden-based cancer drug specialist Kancera has bought Stockholm-headquartered discovery and development services provider iNovacia.

Endeavour rolls out thioamides targeting cancer R&D

By Gareth Macdonald

UK-based Endeavour Specialty Chemicals has launched a range of thioamide intermediates, citing growing evidence of their potential role in development of new cancer treatments.

CIT to distribute hES based tox test in Europe

By Gareth Macdonald

Non-clinical CRO CIT will distribute Stemina’s hES-based toxicity testing platform to pharmaceutical and cosmetics developers in Europe under an agreement announced late last week.